Improving Diagnosis of Dementia in Parkinson’s Disease: PDCogniCare Australian Program
Objective: PDCogniCare program aims to improve the utility of cognitive evaluation for earlier and effective diagnosis of mild cognitive impairment and dementia in Parkinson's disease…Refining a Claims-Based Severity Rating Scale for Parkinson’s Disease Using Machine Learning
Objective: This project aimed to develop an advanced claims-based algorithm to assign severity level to people with Parkinson’s (PwP) to enhance research on disease progression.…Assessment of the Applicability of the King and PD-PCS Scales in Patients with Parkinson’s Disease and Chronic Pain: a Pilot Study
Objective: To assess the feasibility of comparing the King's Pain Disease Pain Scale (KING) and The Parkinson's Disease Pain Classification System (PD-PCS) in patients with…Co-occurrence of Parkinson Disease and Myasthenia Gravis in Hospitalized Patients: A Nationwide Analysis
Objective: To investigate the prevalence of Parkinson disease and myasthenia gravis co-occurrence among hospitalized patients in the United States. Background: Parkinson disease (PD), a largely…PREDIGT 2.0: A Self-Administered, Two-Step Screening Tool to Identify Individuals with Parkinson’s Disease
Objective: To pilot the 2-step PREDIGT Score model for feasibility and improve it by simplifying both steps. Background: We previously demonstrated that the original PREDIGT…Multimodal Dissection of GALC Variants Linking Olfactory Deficits to Cognitive Decline in Parkinson’s Disease
Objective: Olfactory dysfunction is highly prevalent and often precedes motor symptoms, making it a potential early biomarker for disease progression and cognitive decline in Parkinson's…Neurodegeneration Biomarkers: Correlation between Hippocampal Volume and Cognitive Performance by MoCA Test in Parkinson’s Disease
Objective: This study aims to examine the relationship between hippocampal volume, assessed through magnetic resonance imaging (MRI), and MoCA test scores in patients diagnosed with…Parkinson’s Disease and Movement Disorders Mortality in Tunisia: Insights from the National Information System on Causes-of-Death (2020-2021)
Objective: Our study aimed to describe mortality related to Parkinson's disease (PD) and movement disorders in Tunisia during 2020-2021. Background: Parkinson's disease and related movement…Elucidating Tau and Alpha-synuclein Co-pathology in RAB39b X-linked Parkinson’s Disease.
Objective: Elucidate the mechanisms underlying pathogenesis of X-linked Parkinson’s disease (PD) due to the RAB39B p.G192R mutation. Background: RAB39B p.G192R causes X-linked PD with decreased…A Long-Living Human Tissue Engineered Nigrostriatal Pathway as a Testbed to Study Parkinson’s Disease
Objective: To create a three dimensional (3D) long-living model of human tissue-engineered nigrostriatal pathway (TE-NSP) comprised of discrete somatic and axonal compartments recapitulating the native…
- « Previous Page
- 1
- …
- 21
- 22
- 23
- 24
- 25
- …
- 436
- Next Page »